126 related articles for article (PubMed ID: 35979675)
21. Treatment Approaches and Outcomes for Primary Mediastinal Sarcoma: Analysis of 976 Patients.
Engelhardt KE; DeCamp MM; Yang AD; Bilimoria KY; Odell DD
Ann Thorac Surg; 2018 Aug; 106(2):333-339. PubMed ID: 29729268
[TBL] [Abstract][Full Text] [Related]
22. Causes of death in endometrial cancer survivors: A Surveillance, Epidemiology, and End Result-based analysis.
Xue Q; Che W; Xue L; Zhang X; Wang X; Lyu J
Cancer Med; 2023 May; 12(9):10917-10930. PubMed ID: 36924355
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for early death in primary malignant cardiac tumors: An analysis of over 40 years and 500 patients.
He S; Chen H; Cao Y; Nian F; Xu Y; Chen W; Jiang B; Auchoybur ML; Tao Z; Tang S; Carmichael MJ; Qiu Z; Chen X
Int J Cardiol; 2018 Nov; 270():287-292. PubMed ID: 29960762
[TBL] [Abstract][Full Text] [Related]
24. Nomograms and risk classification systems predicting overall and cancer-specific survival in primary malignant cardiac tumor.
Guan T; Li Y; Qiu Z; Zhang Y; Lin W; Lai Y; Wang K; Shen Y; Du L; Liu C
J Card Surg; 2019 Dec; 34(12):1540-1549. PubMed ID: 31794125
[TBL] [Abstract][Full Text] [Related]
25. Upper-extremity sarcomas in the United States: analysis of the surveillance, epidemiology, and end results database, 1973-1998.
Alderman AK; Kim HM; Kotsis SV; Chung KC
J Hand Surg Am; 2003 May; 28(3):511-8. PubMed ID: 12772113
[TBL] [Abstract][Full Text] [Related]
26. Non-Rhabdomyosarcoma Soft Tissue Sarcomas in Children: A Surveillance, Epidemiology, and End Results Analysis Validating COG Risk Stratifications.
Waxweiler TV; Rusthoven CG; Proper MS; Cost CR; Cost NG; Donaldson N; Garrington T; Greffe BS; Heare T; Macy ME; Liu AK
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):339-48. PubMed ID: 25968827
[TBL] [Abstract][Full Text] [Related]
27. Geographic variation in malignant cardiac tumors and their outcomes: SEER database analysis.
Rahouma M; Khairallah S; Dabsha A; Baudo M; El-Sayed Ahmed MM; Gambardella I; Lau C; Esmail YM; Mohamed A; Girardi L; Gaudino M; Lorusso R; Mick SL
Front Oncol; 2023; 13():1071770. PubMed ID: 36761976
[TBL] [Abstract][Full Text] [Related]
28. Outcomes in patients with primary malignant cardiac tumors: A surveillance, epidemiology, and end results program (SEER) database analysis.
Sheth AR; Grewal US; Thotamgari SR; Shi R
J Card Surg; 2021 Sep; 36(9):3463-3465. PubMed ID: 34091949
[No Abstract] [Full Text] [Related]
29. The incidence and survival outcomes of patients with primary cardiac lymphoma: A SEER-based analysis.
Xiao M; Lin J; Xiao T; Lin Y; Ye Y
Hematol Oncol; 2020 Aug; 38(3):334-343. PubMed ID: 32311106
[TBL] [Abstract][Full Text] [Related]
30. Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.
Jacobs AJ; Morris CD; Levin AS
Clin Orthop Relat Res; 2018 Mar; 476(3):589-598. PubMed ID: 29529647
[TBL] [Abstract][Full Text] [Related]
31. Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.
Smartt AA; Jang ES; Tyler WK
Clin Orthop Relat Res; 2020 Mar; 478(3):527-536. PubMed ID: 31390340
[TBL] [Abstract][Full Text] [Related]
32. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
[TBL] [Abstract][Full Text] [Related]
33. Age and treatment disparities in survival of primary malignant cardiac tumors: an analysis of over 40 years and 500 patients.
Wang W; Kang L; Zhang J; Li H; Cao T; He S
J Thorac Dis; 2023 Aug; 15(8):4434-4444. PubMed ID: 37691678
[TBL] [Abstract][Full Text] [Related]
34. Stroke as a cause of death in patients with cancer: a SEER-based study.
Sonbol YT; Elgenidy A; Awad AK; Elmehrath AO; Kobeissi H; Afifi AM; Ghozy S
J Stroke Cerebrovasc Dis; 2023 Aug; 32(8):107154. PubMed ID: 37172472
[TBL] [Abstract][Full Text] [Related]
35. Limb-sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high-grade, extremity soft-tissue sarcoma from the NCDB and SEER.
Ramey SJ; Yechieli R; Zhao W; Kodiyan J; Asher D; Chinea FM; Patel V; Reis IM; Wang L; Wilky BA; Subhawong T; Trent JC
Cancer Med; 2018 Sep; 7(9):4228-4239. PubMed ID: 30030882
[TBL] [Abstract][Full Text] [Related]
36. High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid.
Wang S; Ge C
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10203-10215. PubMed ID: 37270459
[TBL] [Abstract][Full Text] [Related]
37. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.
Galper S; Gelman R; Recht A; Silver B; Kohli A; Wong JS; Van Buren T; Baldini EH; Harris JR
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):406-14. PubMed ID: 11872286
[TBL] [Abstract][Full Text] [Related]
38. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
39. Risk of chronic liver disease and cirrhosis mortality among patients with digestive system cancers: a registry-based analysis.
Sun S; Shi D; Wang W
Clin Exp Med; 2023 Dec; 23(8):5355-5365. PubMed ID: 37787867
[TBL] [Abstract][Full Text] [Related]
40. Reduced Risk of All-Cause, Cancer-, and Cardiovascular Disease-Related Mortality among Patients with Primary Malignant Cardiac Tumors Receiving Chemotherapy in the United States.
Appiah D; Goodart CR; Kothari GK; Ebong IA; Nwabuo CC
Curr Oncol; 2023 Sep; 30(9):8488-8500. PubMed ID: 37754533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
